TRAF2 and neoplasm: Indeed, Vredevoogd et al. (2019) found a TNF response signature in patients responding to an immune checkpoint blockade and identified TRAF2 as a major factor preventing tumor cell death-induction by CD8+ T-cell produced TNF in animal models.